Business
Currency:USD
2024/FY
Stock NameRevenueRatio
Discovery, development and commercialization of innovative medicines in areas of unmet medical need28.75B100.00%
Region
Currency:USD
2024/FY
Stock NameRevenueRatio
United States20.59B71.61%
Europe4.63B16.12%
Other international3.53B12.27%